Trial intelligence / Profile preview

Retinoic acid versus mandelic acid peeling for oily facial skin with acne-related blemishes in women

RBR-6d9657Recruiting

Sponsor
Universidade Federal de Mato Grosso do Sul
Start
May 2017
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of tretinoin and (S)-mandelic acid in acne vulgaris and Post-inflammatory hyperpigmentation (PIH) (3 arms), sponsored by Universidade Federal de Mato Grosso do Sul. Started May 2017; status: recruiting.

02

Drugs

tretinoin(S)-mandelic acid
03

Conditions

acne vulgarisPost-inflammatory hyperpigmentation (PIH)

Beyond the preview

Go deeper on RBR-6d9657.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-6d9657.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call